AAAAAA
Results: 26-50/54
Authors:
BRYANT HU
COLE HW
ADRIAN MD
WILSON PK
SATO M
Citation: Hu. Bryant et al., RALOXIFENE AND ESTROGEN PRESERVE PTH INDUCED BONE MASS IN OVARIECTOMIZED RATS, The FASEB journal, 10(3), 1996, pp. 2705-2705
Authors:
KAUFFMAN RF
BENSCH WR
MAGEE DE
GLASEBROOK AL
BRYANT HU
Citation: Rf. Kauffman et al., HYPOCHOLESTEROLEMIC ACTIVITY OF RALOXIFENE (LY13948-CENTER-DOT-HCL) -PHARMACOLOGICAL CHARACTERIZATION AS A SELECTIVE ESTROGEN-RECEPTOR MODULATOR (SERM), The FASEB journal, 10(3), 1996, pp. 4099-4099
Authors:
SHETLER PK
ROWLEY ER
COLE HW
ADRIAN MD
MAGEE DE
PELL T
SATO M
BRYANT HU
Citation: Pk. Shetler et al., RALOXIFENE, ESTROGEN, LY117018, AND TESTOSTERONE IN STEROID-HORMONE DEFICIENT MALE-RAT, Journal of bone and mineral research, 11, 1996, pp. 585-585
Authors:
MAGEE DE
EVANS G
SATO M
COLE KH
TURNER RT
BRYANT HU
Citation: De. Magee et al., RALOXIFENE (LY139481-CENTER-DOT-HCL) DOES NOT ANTAGONIZE THE EFFECTS OF ESTROGEN ON BONE, Journal of bone and mineral research, 11, 1996, pp. 587-587
Authors:
SATO M
ZENG G
PELL T
BRYANT HU
Citation: M. Sato et al., ANTIRESORPTIVES COMPARED TO HUMAN BIOSYNTHETIC PARATHYROID-HORMONE-(1-34) IN OSTEOPENIC RATS, Journal of bone and mineral research, 11, 1996, pp. 609-609
Authors:
SHORT L
GLASEBROOK AL
ADRIAN MD
COLE H
SHETLER P
ROWLEY ER
MAGEE DE
PELL T
ZENG G
SATO M
BRYANT HU
Citation: L. Short et al., DISTINCT EFFECTS OF SELECTIVE ESTROGEN-RECEPTOR MODULATORS ON ESTROGEN-DEPENDENT AND ESTROGEN-INDEPENDENT HUMAN BREAST-CANCER CELL-PROLIFERATION, Journal of bone and mineral research, 11, 1996, pp. 731-731
Authors:
BRYANT HU
NELSON DL
BUTTON D
COLE HW
BAEZ MB
LUCAITES VL
WAINSCOTT DB
WHITESITT C
REEL J
SIMON R
KOPPEL GA
Citation: Hu. Bryant et al., A NOVEL CLASS OF 5-HT2A RECEPTOR ANTAGONISTS - ARYL AMINOGUANIDINES, Life sciences, 59(15), 1996, pp. 1259-1268
Authors:
SATO M
BRYANT HU
IVERSEN P
HELTERBRAND J
SMIETANA F
BEMIS K
HIGGS R
TURNER CH
OWAN I
TAKANO Y
BURR DB
Citation: M. Sato et al., ADVANTAGES OF RALOXIFENE OVER ALENDRONATE OR ESTROGEN ON NONREPRODUCTIVE AND REPRODUCTIVE TISSUES IN THE LONG-TERM DOSING OF OVARIECTOMIZEDRATS, The Journal of pharmacology and experimental therapeutics, 279(1), 1996, pp. 298-305
Authors:
SATO M
BRYANT HU
DODGE JA
DAVIS H
MATTER WF
VLAHOS CJ
Citation: M. Sato et al., EFFECTS OF WORTMANNIN ANALOGS ON BONE IN-VITRO AND IN-VIVO, The Journal of pharmacology and experimental therapeutics, 277(1), 1996, pp. 543-550
Authors:
LEE W
LOZA J
EDGERTON M
BRYANT HU
TURNER AS
Citation: W. Lee et al., EFFECT OF OVARIECTOMY ON MANDIBULAR BONE IN EWES, Journal of dental research, 75, 1996, pp. 1579-1579
Authors:
YANG NN
BRYANT HU
HARDIKAR S
SATO M
GALVIN RJS
GLASEBROOK AL
TERMINE JD
Citation: Nn. Yang et al., ESTROGEN AND RALOXIFENE STIMULATE TRANSFORMING GROWTH FACTOR-BETA-3 GENE-EXPRESSION IN RAT BONE - A POTENTIAL MECHANISM FOR ESTROGEN-MEDIATED OR RALOXIFENE-MEDIATED BONE MAINTENANCE, Endocrinology, 137(5), 1996, pp. 2075-2084
Authors:
EVANS GL
BRYANT HU
MAGEE DE
TURNER RT
Citation: Gl. Evans et al., RALOXIFENE INHIBITS BONE TURNOVER AND PREVENTS FURTHER CANCELLOUS BONE LOSS IN ADULT OVARIECTOMIZED RATS WITH ESTABLISHED OSTEOPENIA, Endocrinology, 137(10), 1996, pp. 4139-4144
Authors:
TURNER AS
MALLINCKRODT CH
ALVIS MR
BRYANT HU
Citation: As. Turner et al., DUAL-ENERGY X-RAY ABSORPTIOMETRY IN SHEEP - EXPERIENCES WITH IN-VIVO AND EX-VIVO STUDIES, Bone, 17(4), 1995, pp. 381-387
Authors:
TURNER AS
MALLINCKRODT CH
ALVIS MR
BRYANT HU
Citation: As. Turner et al., DOSE-RESPONSE EFFECTS OF ESTRADIOL IMPLANTS ON BONE-MINERAL DENSITY IN OVARIECTOMIZED EWES, Bone, 17(4), 1995, pp. 421-427
Authors:
DODGE JA
BRYANT HU
KIM J
MATTER WF
NORMAN BH
SRINIVASAN U
VLAHOS CJ
SATO M
Citation: Ja. Dodge et al., 17-BETA-HYDROXYWORTMANNIN - A POTENT INHIBITOR OF BONE-RESORPTION ANDPHOSPHATIDYLINOSITOL-3-KINASE, Bioorganic & medicinal chemistry letters, 5(15), 1995, pp. 1713-1718
Authors:
DODGE JA
VLAHOS CJ
MATTER WF
BRYANT HU
NORMAN BH
SRINIVASSAN U
SATO M
Citation: Ja. Dodge et al., IN-VIVO BONE EFFECTS OF 17-BETA-HYDROXYWORTMANNIN IN THE OVARIECTOMIZED (OVX) RAT - THE ROLE OF OSTEOCLAST DIFFERENTIATION AND PHOSPHATIDYLINOSITOL-3-KINASE INHIBITION, Journal of bone and mineral research, 10, 1995, pp. 428-428
Authors:
GRESE TA
BRYANT HU
COLE HW
KIM JR
MAGEE DE
ROWLEY ER
SATO M
Citation: Ta. Grese et al., EFFECTS OF BENZOPYRAN SELECTIVE ESTROGEN-RECEPTOR MODULATORS (SERMS) ON BONE, LIPIDS, AND UTERUS IN OVARIECTOMIZED RATS, Journal of bone and mineral research, 10, 1995, pp. 458-458
Authors:
BRYANT HU
MAGEE DE
COLE HW
ROWLEY ER
WILSON PK
ADRIAN MD
CULLINAN GJ
YANG NN
GLASEBROOK AL
SATO M
Citation: Hu. Bryant et al., LY117018, A SELECTIVE ESTROGEN-RECEPTOR MODULATOR (SERM) IN THE OVARIECTOMIZED RAT, Journal of bone and mineral research, 10, 1995, pp. 459-459
ADVANTAGES OF RALOXIFENE OVER ESTROGEN OR ALENDRONATE IN THE LONG-TERM DOSING OF OVARIECTOMIZED RATS
Authors:
SATO M
BRYANT HU
OWAN I
TAKANO Y
BURR DB
Citation: M. Sato et al., ADVANTAGES OF RALOXIFENE OVER ESTROGEN OR ALENDRONATE IN THE LONG-TERM DOSING OF OVARIECTOMIZED RATS, Journal of bone and mineral research, 10, 1995, pp. 460-460
Authors:
MAGEE DE
EVANS GL
COLE HW
ADRIAN MD
ROWLEY ER
WILSON PK
SATO M
FUCHSYOUNG R
BRYANT HU
TURNER RT
Citation: De. Magee et al., THE EFFECT OF RALOXIFENE (LY139481) IN COMBINATION WITH A PROGESTIN OR AN ANDROGEN IN 6-MONTH-OLD OVARIECTOMIZED (OVX) RATS WITH ESTABLISHED OSTEOPENIA, Journal of bone and mineral research, 10, 1995, pp. 460-460
Authors:
COLE HW
BROWN CE
MAGEE DE
MAGEE C
ROUDEBUSH RE
BRYANT HU
Citation: Hw. Cole et al., SEROTONIN-INDUCED PAW EDEMA IN THE RAT - PHARMACOLOGICAL PROFILE, General pharmacology, 26(2), 1995, pp. 431-436
Authors:
SATO M
KIM J
SHORT LL
SLEMENDA CW
BRYANT HU
Citation: M. Sato et al., LONGITUDINAL AND CROSS-SECTIONAL ANALYSIS OF RALOXIFENE EFFECTS ON TIBIAE FROM OVARIECTOMIZED AGED RATS, The Journal of pharmacology and experimental therapeutics, 272(3), 1995, pp. 1252-1259
Authors:
SATO M
MCCLINTOCK C
KIM J
TURNER CH
BRYANT HU
MAGEE D
SLEMENDA CW
Citation: M. Sato et al., DUAL-ENERGY X-RAY ABSORPTIOMETRY OF RALOXIFENE EFFECTS ON THE LUMBAR VERTEBRAE AND FEMORA OF OVARIECTOMIZED RATS, Journal of bone and mineral research, 9(5), 1994, pp. 715-724
Authors:
BLACK LJ
SATO M
ROWLEY ER
MAGEE DE
BEKELE A
WILLIAMS DC
CULLINAN GJ
BENDELE R
KAUFFMAN RF
BENSCH WR
FROLIK CA
TERMINE JD
BRYANT HU
Citation: Lj. Black et al., RALOXIFENE (LY139481 HCL) PREVENTS BONE LOSS AND REDUCES SERUM-CHOLESTEROL WITHOUT CAUSING UTERINE HYPERTROPHY IN OVARIECTOMIZED RATS, The Journal of clinical investigation, 93(1), 1994, pp. 63-69
Authors:
TURNER CH
SATO M
BRYANT HU
Citation: Ch. Turner et al., RALOXIFENE PRESERVES BONE STRENGTH AND BONE MASS IN OVARIECTOMIZED RATS, Endocrinology, 135(5), 1994, pp. 2001-2005